Clinical Trial Update: Vyvanse in Children Aged 6 to 12 Years [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update for Vyvanse (lisdexamfetamine dimesylate) in children aged 6 to 12 with obesity; early-phase study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Obesity

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: University of Minnesota | Conditions: Obesity, Childhood | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING